A ransomware attack has forced drug research firm Inotiv to shut down critical systems, resulting in operational disruptions. Inotiv is an analytical drug discovery and development service that works with various pharmaceutical companies. It employs over 2,000 research specialists and reports an annual revenue of over $500 million. According to a regulatory filing with the US Securities and Exchange Commission (SEC), Inotiv discovered the cyber attack on 8 August. “On August 8, 2025, Inotiv,
